Takeda completes Shire acquisition
NEW YORK — Takeda Pharmaceutical has completed its acquisition of Shire, 8 months after the deal was announced, according to a press release. The deal was approved by 89.1% of Takeda’s shareholders and 99.8% of Shire’s shareholders, the release said. “We are delighted that the acquisition was approved by an overwhelming majority of our shareholders
